|
|
|
| Effect of Qinqiao Oral Liquid Combined with Montelukast Sodium on the Treatment of Asthmatic Bronchitis in Children |
| YANG Ying |
| Xiangcheng Traditional Chinese Medicine Hospital, Xiangcheng Henan 466200 |
|
|
|
|
Abstract 【Objective】 To investigate the efficacy of Qinqiao oral liquid combined with Montelukast Sodium in the treatment of childhood asthmatic bronchitis.【Methods】 A total of 82 children with asthmatic bronchitis were randomly divided into a control group and a combination group, with 41 cases in each group. The control group received Montelukast Sodium, while the observation group received Montelukast Sodium plus Qinqiao oral liquid. The treatment time in both groups was 4 weeks. The clinical efficacy, improvement time of blood gas [Partial pressure of carbon dioxide(PCO2), blood oxygen saturation(SaO2)], clinical improvement indicators, levels of inflammatory factors [eosinophil cationic protein(ECP) and nitric oxide(NO)], and adverse reactions were compared between the two groups.【Results】 The total clinical effective rate of the observation group was 92.68%(38/41), which was significantly higher than that of the control group(73.17%(30/41). The difference was statistically significant(χ2=5.513, P<0.05).After treatment, the SaO2 level increased in both groups(P<0.05), and the increase in the observation group was higher than that in the control group(P<0.05). The PCO2 level decreased in both groups(P<0.05), and the decrease in the observation group was greater than that in the control group(P<0.05). The observation group had shorter durations of pulmonary wheezing relief, alleviation of wheezing, and resolution of cough compared to the control group(P<0.05). There was no significant difference in the levels of inflammatory factors NO and ECP between the two groups before treatment(P>0.05). After treatment, serum NO and ECP levels in both groups decreased compared to pre-treatment levels, with those in the observation group significantly lower than those in the control group(P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups(χ2=0.554, P=0.457).【Conclusion】 The combination of Qinqiao oral liquid and Montelukast Sodium has significant efficacy in the treatment of childhood asthmatic bronchitis. It effectively regulates blood gas indicators, achieves faster improvement of clinical symptoms in children, reduces inflammatory response, and is safe and reliable.
|
|
Received: 01 March 2025
|
|
|
|
|
|
[1] BIAN F, WU Y E, ZHANG C L. Use of aerosol inhalation treatment with budesonide and terbutaline sulfate on acute pediatric asthmatic bronchitis[J].Exp Ther Med,2017,14(2):1621-1625.
[2] 杨积宝,方英岳,刑春喜. 金贝痰咳清颗粒联合孟鲁司特钠治疗儿童喘息性支气管炎的临床研究[J].现代药物与临床,2019,34(3):750-754.
[3] 叶惠,王婷,陈思航. 孟鲁司特钠对儿童喘息性支气管炎临床疗效及免疫功能的影响[J].贵州医药,2023,47(3):380-381.
[4] 张英,李亚男,高月茹,等.芩翘口服液治疗儿童急性化脓性扁桃体炎的临床研究[J].中医临床研究,2017,9(9):79-81.
[5] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.急性气管-支气管炎基层诊疗指南(实践版·2018)[J].中华全科医师杂志, 2019, 18(4):318-320.
[6] 杨积宝,方英岳,刑春喜.金贝痰咳清颗粒联合孟鲁司特钠治疗儿童喘息性支气管炎的临床研究[J].现代药物与临床,2019,34(3):750-754.
[7] 叶惠,王婷,陈思航. 孟鲁司特钠对儿童喘息性支气管炎临床疗效及免疫功能的影响[J].贵州医药, 2023, 47(3):380-381.
[8] 汤华平,马泽南,邹公民,等.布地奈德联合硫酸镁用于治疗小儿喘息性支气管肺炎的疗效研究[J].系统医学 , 2021, 6(23):121-124.
[9] 袁长亮, 谢新林, 李涛.孟鲁司特钠联合氨溴特罗治疗喘息性支气管炎的效果及对患儿PCT、CRP、IL-6水平的影响[J].临床医学研究与实践, 2022, 7(4):82-84.
[10] 程彦珍. 芩翘口服液配合阿奇霉素干混悬剂治疗急性咽炎疗效观察[J].中国药物与临床,2021,21(4):624-626.
[11] 宁成利,朱占魁,侯杏杏. 喘息性支气管炎患儿经甲泼尼龙和孟鲁司特钠治疗的效果及对运动耐力的影响[J].临床和实验医学杂志,2025,24(1):58-62.
[12] 闫树学,王璇,马晓花. 芩翘口服液联合头孢克肟治疗小儿急性扁桃体炎的临床研究[J].现代药物与临床,2023,38(6):1407.
[13] 张璇,姜睿斌,张晓菊,等. 基于NF-κB通路研究生地黄-玄参对糖尿病肾病大鼠肾脏微炎症状态的影响[J].国际中医中药杂志,2022,44(1):49-55.
[14] 赵士博,张艺馨,卢丹妮,等. 连翘和野菊花及其配伍对高脂血症小鼠血脂、血糖及肝肾功能的影响[J].中国老年学杂志,2023,43(1):97-101. |
|
|
|
2025, Vol. 42 
